The effectiveness of tumor necrosis factor-α blocker therapy in patients with axial spondyloarthritis who failed conventional treatment: a comparative study focused on improvement in ASAS Health Index.
Ah-Ra ChoiKi-Jeong ParkJi-Hyoun KangYu Jeong LeeHyun Hee JangMoon-Ju KimTae Jong KimPublished in: Journal of rheumatic diseases (2024)
The research demonstrates that ASAS-HI scores significantly improve with TNF-α blocker therapy in axSpA patients, underscoring ASAS-HI's effectiveness as a tool for evaluating drug responses.